Scientists have reported encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.
source https://www.sciencedaily.com/releases/2021/10/211022123744.htm
0 comments: